Taxotere (Docetaxel) Products Liability Litigation
Taxotere (Docetaxel) is alleged to cause permanent alopecia through its cytotoxic effects on rapidly dividing hair follicle cells, leading to irreversible hair loss. It can also cause ocular side effects such as tearing, lacrimal duct obstruction, and optic neuropathy, likely due to neurotoxic and ischemic mechanisms affecting ocular tissues. FDA warnings and medical literature support these causation pathways, with expert opinions citing neurotoxicity and ischemia as primary mechanisms.
203
Pending actions
15,572
Total actions filed
Active
Status
10/04/2016
Established
Filing deadline
The general statute of limitations for filing such claims is typically 2-4 years from injury or discovery. Specific procedural deadlines set by the court include a deadline for applications for court-appointed positions on November 30, 2017, and amended deadlines in 2021. The court has also signaled active settlement discussions with filing deadlines for relevant spreadsheets by October 16, 2023.
Who qualifies
Plaintiffs must have used Taxotere (or Docetaxel) for cancer treatment, typically breast cancer, with sufficient exposure to cause the alleged injuries. While explicit dosage thresholds or specific timeframes are not publicly detailed, plaintiffs are required to submit detailed exposure information via Plaintiff Fact Sheets, including duration and dosage. Court orders emphasize the importance of documented drug exposure, but do not specify minimum dosage or duration thresholds in publicly available documents.
Products involved
- Taxotere
- Docetaxel
Alleged injuries
- permanent hair loss (alopecia)
- eye damage including vision loss and tearing
Bellwether trials
The second bellwether trial was scheduled to begin on November 8, 2021. The MDL has experienced a slight decrease in pending cases, from 375 to 373 as of early 2026. The first trial verdict was overturned on February 10, 2022, indicating ongoing appellate activity. Multiple claims involving hair loss and eye injuries are ongoing, with some settlements ranging from $20,000 to over $300,000.
Settlement landscape
Settlement estimates for individual cases range from approximately $20,000 to over $300,000, depending on injury severity and case specifics. No court-approved settlement programs or final payouts have been publicly announced as of early 2026.
Lead counsel
- Kirk T. Stange (Stange Law Firm, PC)
- James C. Beasley Jr. (Beasley Allen Law Firm)
- Michael J. Miller (Miller Law LLC)
- L. Timothy Fisher (Girard Sharp LLP)
- Robert C. Hilliard (Hilliard Martinez Gonzales LLP)
- D. Todd Ridley (Ridley McGreevy & Winocur LLP)
This page is generated from the official JPML pending-MDL report and public court records, refreshed monthly. It is provided for attorney reference and is not legal advice.
